Overview
Takahiro Kishikawa practices in Tokyo, Japan. Mr. Kishikawa is rated as an Advanced expert by MediFind in the treatment of Ruvalcaba Syndrome. His top areas of expertise are Ruvalcaba Syndrome, Pancreatic Cancer, Liver Cancer, and Hepatitis.
His clinical research consists of co-authoring 60 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Ruvalcaba Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pancreatic CancerMr. Kishikawa isAdvanced. Learn about Pancreatic Cancer.
- Ruvalcaba SyndromeMr. Kishikawa isAdvanced. Learn about Ruvalcaba Syndrome.
- Experienced
- Bannayan-Riley-Ruvalcaba SyndromeMr. Kishikawa isExperienced. Learn about Bannayan-Riley-Ruvalcaba Syndrome.
- CholangitisMr. Kishikawa isExperienced. Learn about Cholangitis.
- CirrhosisMr. Kishikawa isExperienced. Learn about Cirrhosis.
- Cowden SyndromeMr. Kishikawa isExperienced. Learn about Cowden Syndrome.
- HepatitisMr. Kishikawa isExperienced. Learn about Hepatitis.
- Hepatitis BMr. Kishikawa isExperienced. Learn about Hepatitis B.